Moriyama M - Search Results

1

Gut-Microbiota Dysbiosis in Stroke-Prone Spontaneously Hypertensive Rats with Diet-Induced Steatohepatitis.

Kanezawa S, Moriyama M, Kanda T, Fukushima A, Masuzaki R, Sasaki-Tanaka R, Tsunemi A, Ueno T, Fukuda N, Kogure H. Kanezawa S, et al. Among authors: moriyama m. Int J Mol Sci. 2023 Feb 27;24(5):4603. doi: 10.3390/ijms24054603. Int J Mol Sci. 2023. PMID: 36902037 Free PMC article.

2

Removal of hepatitis C virus by G-1 beads in sera from patients with chronic hepatitis C.

Moriyama M, Kaneko M, Matsumura H, Fukushima A, Aoki H, Tanaka N, Kuroda K, Shimizu K, Hiraishi K, Arakawa Y. Moriyama M, et al. Intervirology. 2005;48(2-3):84-8. doi: 10.1159/000081733. Intervirology. 2005. PMID: 15812179

3

Clinical significance of evaluation of serum zinc concentrations in C-viral chronic liver disease.

Moriyama M, Matsumura H, Fukushima A, Ohkido K, Arakawa Y, Nirei K, Yamagami H, Kaneko M, Tanaka N, Arakawa Y. Moriyama M, et al. Dig Dis Sci. 2006 Nov;51(11):1967-77. doi: 10.1007/s10620-005-9051-7. Epub 2006 Oct 18. Dig Dis Sci. 2006. PMID: 17048113

4

Development of a chimeric DNA-RNA hammerhead ribozyme targeting SARS virus.

Fukushima A, Fukuda N, Lai Y, Ueno T, Moriyama M, Taguchi F, Iguchi A, Shimizu K, Kuroda K. Fukushima A, et al. Among authors: moriyama m. Intervirology. 2009;52(2):92-9. doi: 10.1159/000215946. Epub 2009 May 7. Intervirology. 2009. PMID: 19420961 Free PMC article.

5

HCV NS5A resistance-associated variants in a group of real-world Japanese patients chronically infected with HCV genotype 1b.

Hirotsu Y, Kanda T, Matsumura H, Moriyama M, Yokosuka O, Omata M. Hirotsu Y, et al. Among authors: moriyama m. Hepatol Int. 2015 Jul;9(3):424-30. doi: 10.1007/s12072-015-9624-2. Epub 2015 Mar 20. Hepatol Int. 2015. PMID: 25791176

6

Reduction of Dimethylnitrosamine-Induced Liver Fibrosis by the Novel Gene Regulator PI Polyamide Targeting Transforming Growth Factor β1 Gene.

Inami M, Fukushima A, Ueno T, Yamada T, Tsunemi A, Matsumoto Y, Fukuda N, Soma M, Moriyama M. Inami M, et al. Among authors: moriyama m. Biol Pharm Bull. 2015;38(12):1836-42. doi: 10.1248/bpb.b15-00328. Epub 2015 Sep 16. Biol Pharm Bull. 2015. PMID: 26377734 Free article.

7

[Prevention of hepatitis E virus].

Kanezawa SI, Matsuoka S, Moriyama M. Kanezawa SI, et al. Among authors: moriyama m. Nihon Rinsho. 2015 Dec;73 Suppl 9:636-8. Nihon Rinsho. 2015. PMID: 26846011 Japanese. No abstract available.

8

Steatosis influences the clinical profiles and long-term outcomes of interferon-treated chronic hepatitis C and liver cirrhosis patients.

Nirei K, Matsumura H, Kumakawa M, Matsumoto N, Nakamura H, Yamagami H, Matsuoka S, Moriyama M. Nirei K, et al. Among authors: moriyama m. Int J Med Sci. 2017 Jan 1;14(1):45-52. doi: 10.7150/ijms.17202. eCollection 2017. Int J Med Sci. 2017. PMID: 28138308 Free PMC article.

9

Direct-acting antiviral agents against hepatitis C virus and lipid metabolism.

Kanda T, Moriyama M. Kanda T, et al. Among authors: moriyama m. World J Gastroenterol. 2017 Aug 21;23(31):5645-5649. doi: 10.3748/wjg.v23.i31.5645. World J Gastroenterol. 2017. PMID: 28883690 Free PMC article.

10

Hepatitis B Virus Genotype C is Predominant in Myanmar.

Nwe Win N, Nakamoto S, Myint Sein M, Moriyama M, Kanda T, Shirasawa H. Nwe Win N, et al. Among authors: moriyama m. Diseases. 2017 Dec 26;6(1):3. doi: 10.3390/diseases6010003. Diseases. 2017. PMID: 29278399 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,434 results

Search Page

Filters